Cargando…

Reproducibility of serum IgE, Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children

BACKGROUND: Ara h2 sIgE serum levels improve the diagnostic accuracy for predicting peanut allergy, but the use of Ara h2 purified protein as a skin prick test (SPT), has not been substantially evaluated. The fraction of exhaled nitric oxide (FeNO) shows promise as a novel biomarker of peanut allerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Percival, Elizabeth, Bhatia, Rani, Preece, Kahn, McElduff, Patrick, McEvoy, Mark, Collison, Adam, Mattes, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975907/
https://www.ncbi.nlm.nih.gov/pubmed/27499764
http://dx.doi.org/10.1186/s13223-016-0143-z
_version_ 1782446797119029248
author Percival, Elizabeth
Bhatia, Rani
Preece, Kahn
McElduff, Patrick
McEvoy, Mark
Collison, Adam
Mattes, Joerg
author_facet Percival, Elizabeth
Bhatia, Rani
Preece, Kahn
McElduff, Patrick
McEvoy, Mark
Collison, Adam
Mattes, Joerg
author_sort Percival, Elizabeth
collection PubMed
description BACKGROUND: Ara h2 sIgE serum levels improve the diagnostic accuracy for predicting peanut allergy, but the use of Ara h2 purified protein as a skin prick test (SPT), has not been substantially evaluated. The fraction of exhaled nitric oxide (FeNO) shows promise as a novel biomarker of peanut allergy. Reproducibility of these measures has not been determined. The aim was to assess the accuracy and reproducibility (over a time-period of at least 12 months) of SPT to Ara h2 in comparison with four predictors of clinical peanut allergy (Peanut SPT, Ara h2 specific Immunoglobulin E (sIgE), Peanut sIgE and FeNO). METHODS: Twenty-seven children were recruited in a follow-up of a prospective cohort of fifty-six children at least 12 months after an open-labelled peanut food challenge. Their repeat assessment involved a questionnaire, SPT to peanut and Ara h2 purified protein, FeNO and sIgE to peanut and Ara h2 measurements. RESULTS: Ara h2 SPT was no worse in accuracy when compared with peanut SPT, FeNO, Ara h2 sIgE and peanut sIgE (AUC 0.908 compared with 0.887, 0.889, 0.935 and 0.804 respectively) for predicting allergic reaction at previous food challenge. SPT for peanut and Ara h2 demonstrated limited reproducibility (ICC = 0.51 and 0.44); while FeNO demonstrated good reproducibility (ICC = 0.73) and sIgE for peanut and Ara h2 were highly reproducible (ICC = 0.81 and 0.85). CONCLUSIONS: In this population, Ara h2 SPT was no worse in accuracy when compared with current testing for the evaluation of clinical peanut allergy, but had—like peanut SPT—poor reproducibility. FeNO, peanut sIgE and Ara h2 sIgE were consistently reproducible despite an interval of at least 12 months between the repeated measurements. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13223-016-0143-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4975907
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49759072016-08-07 Reproducibility of serum IgE, Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children Percival, Elizabeth Bhatia, Rani Preece, Kahn McElduff, Patrick McEvoy, Mark Collison, Adam Mattes, Joerg Allergy Asthma Clin Immunol Research BACKGROUND: Ara h2 sIgE serum levels improve the diagnostic accuracy for predicting peanut allergy, but the use of Ara h2 purified protein as a skin prick test (SPT), has not been substantially evaluated. The fraction of exhaled nitric oxide (FeNO) shows promise as a novel biomarker of peanut allergy. Reproducibility of these measures has not been determined. The aim was to assess the accuracy and reproducibility (over a time-period of at least 12 months) of SPT to Ara h2 in comparison with four predictors of clinical peanut allergy (Peanut SPT, Ara h2 specific Immunoglobulin E (sIgE), Peanut sIgE and FeNO). METHODS: Twenty-seven children were recruited in a follow-up of a prospective cohort of fifty-six children at least 12 months after an open-labelled peanut food challenge. Their repeat assessment involved a questionnaire, SPT to peanut and Ara h2 purified protein, FeNO and sIgE to peanut and Ara h2 measurements. RESULTS: Ara h2 SPT was no worse in accuracy when compared with peanut SPT, FeNO, Ara h2 sIgE and peanut sIgE (AUC 0.908 compared with 0.887, 0.889, 0.935 and 0.804 respectively) for predicting allergic reaction at previous food challenge. SPT for peanut and Ara h2 demonstrated limited reproducibility (ICC = 0.51 and 0.44); while FeNO demonstrated good reproducibility (ICC = 0.73) and sIgE for peanut and Ara h2 were highly reproducible (ICC = 0.81 and 0.85). CONCLUSIONS: In this population, Ara h2 SPT was no worse in accuracy when compared with current testing for the evaluation of clinical peanut allergy, but had—like peanut SPT—poor reproducibility. FeNO, peanut sIgE and Ara h2 sIgE were consistently reproducible despite an interval of at least 12 months between the repeated measurements. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13223-016-0143-z) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-05 /pmc/articles/PMC4975907/ /pubmed/27499764 http://dx.doi.org/10.1186/s13223-016-0143-z Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Percival, Elizabeth
Bhatia, Rani
Preece, Kahn
McElduff, Patrick
McEvoy, Mark
Collison, Adam
Mattes, Joerg
Reproducibility of serum IgE, Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children
title Reproducibility of serum IgE, Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children
title_full Reproducibility of serum IgE, Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children
title_fullStr Reproducibility of serum IgE, Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children
title_full_unstemmed Reproducibility of serum IgE, Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children
title_short Reproducibility of serum IgE, Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children
title_sort reproducibility of serum ige, ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975907/
https://www.ncbi.nlm.nih.gov/pubmed/27499764
http://dx.doi.org/10.1186/s13223-016-0143-z
work_keys_str_mv AT percivalelizabeth reproducibilityofserumigearah2skinpricktestingandfractionofexhalednitricoxideforpredictingclinicalpeanutallergyinchildren
AT bhatiarani reproducibilityofserumigearah2skinpricktestingandfractionofexhalednitricoxideforpredictingclinicalpeanutallergyinchildren
AT preecekahn reproducibilityofserumigearah2skinpricktestingandfractionofexhalednitricoxideforpredictingclinicalpeanutallergyinchildren
AT mcelduffpatrick reproducibilityofserumigearah2skinpricktestingandfractionofexhalednitricoxideforpredictingclinicalpeanutallergyinchildren
AT mcevoymark reproducibilityofserumigearah2skinpricktestingandfractionofexhalednitricoxideforpredictingclinicalpeanutallergyinchildren
AT collisonadam reproducibilityofserumigearah2skinpricktestingandfractionofexhalednitricoxideforpredictingclinicalpeanutallergyinchildren
AT mattesjoerg reproducibilityofserumigearah2skinpricktestingandfractionofexhalednitricoxideforpredictingclinicalpeanutallergyinchildren